Advancing Regulatory Pathways for Complex In Vitro Models to Enhance Predictive Toxicity Assessments
- Establishing evidentiary considerations for model validation and qualification to align with global health authority requirements and standards
- Identifying context of use and unmet needs for complex in vitro models to address near-term regulatory applications
- Integrating models throughout pharmaceutical pipelines from high-throughput screening to IND applications to accelerate development timelines